3 Pet Stocks Wall Street Predicts Will Rally 30% or More

NASDAQ: FRPT | Freshpet, Inc. News, Ratings, and Charts

FRPT – Because the remote lifestyle kicked off a pet adoption and parenting trend, there has been a substantial rise in the sale of pet supplies and pet care products. And because the pet care market is expected to continue growing, Wall Street analysts expect prominent players in this space, Freshpet (FRPT), The Original BARK Company (BARK), and PetIQ (PETQ), to deliver substantial returns in the coming months. Let’s discuss.

The COVID-19 pandemic-driven embrace of remote lifestyles heightened interest in pet adoption as homebound individuals yearned for furry companions. With stay-at-home and work-from-home dynamics deepening bonds between pet owners and pets, pet owners are spending generously on pet food products and veterinary services to keep their pets healthy and happy.

The global pet market is expected to reach $241.1 billion by 2026, registering a 5.2% CAGR. A shift in preference to branded pet products, the convenience of e-commerce platforms, and branding by pet suppliers are expected to further propel the industry’s growth.

Hence, Wall Street analysts are optimistic about the growth potential of several quality pet care stocks. Indeed, the Street expects the shares of Freshpet Inc. (FRPT), The Original BARK Company (BARK), and PetIQ, Inc. (PETQ) to rally by more than 30% in price in the coming months.

Freshpet Inc. (FRPT)

FRPT is a Secaucus, N.J.-based pet food company that provides natural, locally sourced, preservative-free and fresh food for dogs and cats. Freshpet Select, Dog Joy, Deli Fresh, Homestyle Creations, Fresh Treats, Vital, Nature’s Fresh, and Dognation are the brands under which the company markets its products. In addition, the company’s Freshpet Kitchens are registered with APHIS and the FDA.

In August, FRPT released its inaugural Environmental, Social, and Governance (ESG) Sustainability report, “Nourishing Pets, People and Planet.” The report articulates the company’s ambition to strengthen the bond between its customers and their pets by offering natural and sustainable pet foods to help them live longer and healthier lives.

FRPT’s net sales for the second quarter, ended June 30, 2021, increased 35.8% year-over-year to $108.62 million. The company’s gross profit increased 27% from its year-ago value to $43.09 million. Its cash and cash equivalents grew 160.2% from the prior-year quarter to $280.32 million in the six months ended June 30, 2021.

Analysts expect FRPT’s revenue for its  fiscal year 2021 to be $445.81 million, representing 39.8% year-over-year growth. The company’s EPS is expected to increase by 1,266.7% next year. Furthermore,  the stock has gained 17.4% in price over the past year.

Of the seven Wall Street analysts that have provided ratings for the stock, four rated it Buy. Closing yesterday’s trading session at $133.92, the $174.71 average analyst price target represents a 30.5% potential gain.

The Original BARK Company (BARK)

BARK is a dog-oriented company that is headquartered in New York City. It  provides personalized food, a box of themed toys and treats, super-tough toys and chews, and dental kits for dogs. BARK Eats, BARK Box, BARK Super chewer, and BARK Bright are the brands under which the company markets its products. BARK operates in two segments, Direct to Consumer and Commerce.

In August, ProShare announced Pet Care ETF would hold BARK because the company has the potential to capitalize on the proliferation of pet ownership and respond to the new trends in the market. This addition to the fund’s holdings will allow investors to gain broad exposure to BARK’s potential growth within the industry.

In July, BARK and the Dunkin’ Joy in Childhood Foundation collaborated for the second time to feature two “pawsome” new dog toys and Dunkin’ themed dog toys with coffee cup, donut, and bag. The dog owners can avail themselves of these limited-edition toys through BARKShop.com. In addition, BarkBox and Super Chewer subscribers could access these toys through Add-to-Box.

For its fiscal first quarter, ended June 30, 2021, BARK’s revenue increased 57.2% year-over-year to $117.61 million. The company’s gross profit increased 48.7% from its  year-ago value to $69.79 million. In addition, its quarterly subscription shipments increased 52.4% from the prior-year quarter to $3.6 million. Its gross margin stood at 59.3% for the quarter.

BARK’s revenue is expected to increase 36.7% year-over-year to $708.14 million in the fiscal period ending March 2023. Its EPS is estimated to grow 95% in fiscal 2022 and 33.9% in fiscal 2023. Over the past month, the stock climbed  6.8%. In price.

All three Wall Street analysts that provided ratings for the stock rated it Buy. The  $15.33 consensus price target represents a 79.7% potential gain from the last closing price of $8.53.

PetIQ, Inc. (PETQ)

Eagle, Idaho-based company PETQ is one of the leading pet health products companies. PETQ provides pet owners a smarter approach to pet health and creates exceptional value for retailers, manufacturers, and shareholders. PetArmor, Capstar, Sentry, Advecta, Minties, Sergeants, VetIQ, PetAction, CapAction, and PurLuv are the brands under which PETQ sells its products and services.

In April, PETQ established a  new $425 million credit facility. As a result, the company received a $300 million  loan and a $125 million new asset-based revolving line of credit. For this new credit facility, PETQ partnered with Jefferies Finance LLC and KeyBank National Association. The partnership will decrease its  annual interest rate by 125-basis points and support the company by offering financial flexibility and future growth.

PETQ’s total net sales increased 1.5% year-over-year to $271.01 million for the second quarter, ended June 30, 2021. The company’s gross profit increased 41.4% from its year-ago value to $59.63 million. Its operating income increased 346.5% from the prior-year quarter to $16.49 million. PETQ’s net income amounted to $4.03 million for the quarter, versus a  $1.45 million net loss in the prior-year period.

For its  fiscal year 2021, PETQ’s revenue is estimated to be $889.25 million, representing 14% year-over-year growth. Analysts expect PETQ’s EPS to increase 181.8% next quarter and 64.2% in the current year.

The only Wall Street analyst that provided a rating for the stock rated it Buy. Currently trading at $26.78, the $45 average analyst price target  represents a 68 4% potential upside.


FRPT shares were trading at $132.18 per share on Friday afternoon, down $1.74 (-1.30%). Year-to-date, FRPT has declined -6.91%, versus a 21.85% rise in the benchmark S&P 500 index during the same period.


About the Author: Imon Ghosh


Imon is an investment analyst and journalist with an enthusiasm for financial research and writing. She began her career at Kantar IMRB, a leading market research and consumer consulting organization. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
FRPTGet RatingGet RatingGet Rating
BARKGet RatingGet RatingGet Rating
PETQGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2 Best Stocks of All Time!

This bear market has me thinking back to my 2 best trades of all time. That being when I bought Amazon (AMZN) and Booking (BKNG) back in 2001 as they were tumbling down in the midst of a bear market...but now enjoying truly phenomenal gains. Let’s discuss what those investments had in common and how that will help us find more big winners in the years ahead. Read on below for more...

:  |  News, Ratings, and Charts

Bears Back in Charge...What Happens Next?

A month ago the bulls were claiming victory as they created a charge back over 4,000 for the S&P 500 (SPY). Since then that false narrative has been peeled away and investors are more honestly looking at the bleak outlook formed by high inflation and a hawkish Fed. That explains why we are back retesting the June lows. Now we have to ponder what comes next and how to trade our way to profits. Read on below for the full story...

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

:  |  News, Ratings, and Charts

Cut These 2 Stocks From Your Portfolio Right Now

The Fed succeeding in a ‘soft landing’ seems unlikely. Analysts are expecting a recession soon. So, with the rising odds of the Fed raising rates aggressively, it could be wise to steer clear of fundamentally weak stocks Roblox (RBLX) and Affirm Holdings (AFRM). Read on…

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

Read More Stories

More Freshpet, Inc. (FRPT) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All FRPT News